Skip to content

Drug interactions

Eslicarbazepine + Ripretinib

Severity: Moderate

Eslicarbazepine and Ripretinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine may lower ripretinib and its active metabolite concentrations, which could reduce antitumor efficacy.

What this interaction means in plain words

Eslicarbazepine and Ripretinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eslicarbazepine belongs to Central Nervous System; Ripretinib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 induction increases the metabolism of ripretinib.

What to do

Prefer a non-inducing anticonvulsant if possible. If not, monitor tumor response and consider the labeled increase in ripretinib frequency, although labeling targets strong inducers.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Ripretinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Ripretinib?

MediHelp rates the interaction as moderate. Eslicarbazepine and Ripretinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eslicarbazepine may lower ripretinib and its active metabolite concentrations, which could reduce antitumor efficacy.

How serious is the interaction between Eslicarbazepine and Ripretinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing anticonvulsant if possible. If not, monitor tumor response and consider the labeled increase in ripretinib frequency, although labeling targets strong inducers.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in